Fengfeng Xu

976 total citations
33 papers, 777 citations indexed

About

Fengfeng Xu is a scholar working on Molecular Biology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fengfeng Xu has authored 33 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Neurology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fengfeng Xu's work include Intracranial Aneurysms: Treatment and Complications (7 papers), Cerebrovascular and Carotid Artery Diseases (5 papers) and Microtubule and mitosis dynamics (4 papers). Fengfeng Xu is often cited by papers focused on Intracranial Aneurysms: Treatment and Complications (7 papers), Cerebrovascular and Carotid Artery Diseases (5 papers) and Microtubule and mitosis dynamics (4 papers). Fengfeng Xu collaborates with scholars based in China and United States. Fengfeng Xu's co-authors include Stanley N. Cohen, Liang Deng, Jihong Zhang, Shibin Yang, William S. Saunders, Jihong Yang, Hongwu Chen, John S. Lazo, Haishuang Tang and Peter Wipf and has published in prestigious journals such as Nature, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Fengfeng Xu

32 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengfeng Xu China 13 604 313 123 58 52 33 777
Masahiko Watanabe Japan 14 216 0.4× 201 0.6× 80 0.7× 16 0.3× 26 0.5× 25 599
Fei Qi China 18 597 1.0× 209 0.7× 37 0.3× 14 0.2× 54 1.0× 48 848
Emmanuel G. Fragoulis Greece 18 516 0.9× 233 0.7× 67 0.5× 15 0.3× 79 1.5× 54 817
Vilius Stribinskis United States 14 1.0k 1.7× 511 1.6× 46 0.4× 12 0.2× 39 0.8× 18 1.3k
Tri M. Bui Nguyen United States 12 352 0.6× 85 0.3× 74 0.6× 27 0.5× 25 0.5× 20 535
Juan Yang China 17 334 0.6× 144 0.5× 26 0.2× 16 0.3× 46 0.9× 52 631
Mukesh Kumar Sharma United States 11 183 0.3× 74 0.2× 50 0.4× 68 1.2× 34 0.7× 26 566
Najma Farahani Iran 13 341 0.6× 131 0.4× 51 0.4× 13 0.2× 37 0.7× 60 611
Gagan B. Panigrahi Canada 19 804 1.3× 104 0.3× 161 1.3× 11 0.2× 25 0.5× 26 1.0k
Megumi Ikeda Japan 11 473 0.8× 225 0.7× 28 0.2× 13 0.2× 154 3.0× 41 839

Countries citing papers authored by Fengfeng Xu

Since Specialization
Citations

This map shows the geographic impact of Fengfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengfeng Xu more than expected).

Fields of papers citing papers by Fengfeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengfeng Xu. The network helps show where Fengfeng Xu may publish in the future.

Co-authorship network of co-authors of Fengfeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengfeng Xu. A scholar is included among the top collaborators of Fengfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengfeng Xu. Fengfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Junjie, Rui Zhao, Fengfeng Xu, et al.. (2023). Discovery of anti-inflammatory natural flavonoids: Diverse scaffolds and promising leads for drug discovery. European Journal of Medicinal Chemistry. 260. 115791–115791. 28 indexed citations
3.
Tang, Haishuang, Sisi Li, Fengfeng Xu, et al.. (2022). Low-profile LEO baby stents using dual stenting technique in treating complex intracranial aneurysms located in small artery: Initial and mid-term outcome. Journal of Clinical Neuroscience. 98. 109–114. 2 indexed citations
4.
Tang, Haishuang, Qiao Zuo, Xiaoxi Zhang, et al.. (2022). Braided stents assisted coiling for endovascular management of posterior cerebral artery aneurysms: a preliminary mid-term experience. Neuroradiology. 64(9). 1847–1856. 4 indexed citations
5.
Tang, Haishuang, Xiaoxi Zhang, Fengfeng Xu, et al.. (2021). The biology of bone morphogenetic protein signaling pathway in cerebrovascular system. Chinese Neurosurgical Journal. 7(1). 36–36. 7 indexed citations
6.
Tang, Haishuang, Zhiwen Lu, Qiao Zuo, et al.. (2021). Endovascular treatment of symptomatic intracranial atherosclerotic stenosis with low profile visualized intraluminal support stent. Journal of Clinical Neuroscience. 90. 256–261. 2 indexed citations
7.
Liu, Peng, Fengfeng Xu, Yibin Fang, et al.. (2021). Endovascular Treatment of Ruptured Wide-Necked Anterior Communicating Artery Aneurysms Using a Low-Profile Visualized Intraluminal Support (LVIS) Device. Frontiers in Neurology. 11. 611875–611875. 3 indexed citations
8.
Yan, Yazhou, Jiachao Xiong, Fengfeng Xu, et al.. (2021). SDF-1α/CXCR4 Pathway Mediates Hemodynamics-Induced Formation of Intracranial Aneurysm by Modulating the Phenotypic Transformation of Vascular Smooth Muscle Cells. Translational Stroke Research. 13(2). 276–286. 13 indexed citations
9.
Xu, Fengfeng, et al.. (2018). Overexpressing lncRNA <em>SNHG16</em> inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93. OncoTargets and Therapy. Volume 11. 8855–8863. 71 indexed citations
10.
Li, Shuangtao, Lei Zhang, Ying Wang, et al.. (2017). Knockdown of a cellulose synthase gene BoiCesA affects the leaf anatomy, cellulose content and salt tolerance in broccoli. Scientific Reports. 7(1). 41397–41397. 20 indexed citations
11.
Xu, Fengfeng, et al.. (2016). Knockdown of TMEM16A suppressed MAPK and inhibited cell proliferation and migration in&nbsp;hepatocellular carcinoma. OncoTargets and Therapy. 9. 325–325. 47 indexed citations
12.
Deng, Liang, Shibin Yang, Fengfeng Xu, & Jihong Zhang. (2015). Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. Journal of Experimental & Clinical Cancer Research. 34(1). 18–18. 239 indexed citations
13.
Xu, Fengfeng, et al.. (2013). Shoulder pain after abdominal laparoscopic operation: a multicenter study. Chinese Medical Journal. 126(2). 382–384. 2 indexed citations
14.
Luo, Di‐Qing, Changzheng Huang, Wenlin Xie, Fengfeng Xu, & Liqiu Mo. (2013). Hybrid Eccrine Gland and Hair Follicle Hamartoma. American Journal of Dermatopathology. 37(2). 167–170. 1 indexed citations
15.
Li, Mingzhe, et al.. (2013). Extended multi-organ resection for cT4 gastric carcinoma: A retrospective analysis. Pakistan Journal of Medical Sciences. 29(2). 581–5. 9 indexed citations
16.
Li, Youjun, Fengfeng Xu, Jie Lu, William S. Saunders, & Edward V. Prochownik. (2010). Widespread Genomic Instability Mediated by a Pathway Involving Glycoprotein Ibα and Aurora B Kinase. Journal of Biological Chemistry. 285(17). 13183–13192. 9 indexed citations
17.
Wu, Qian, Fengfeng Xu, Youjun Li, Edward V. Prochownik, & William S. Saunders. (2010). The c-Myc Target Glycoprotein1bα Links Cytokinesis Failure to Oncogenic Signal Transduction Pathways in Cultured Human Cells. PLoS ONE. 5(5). e10819–e10819. 2 indexed citations
18.
Xu, Fengfeng & William S. Saunders. (2008). Actin and Microtubules: Working Together to Control Spindle Polarity. Cancer Cell. 14(3). 197–199. 7 indexed citations
19.
Graham, Thomas H., Peter Wipf, Fengfeng Xu, et al.. (2008). Microtubule Binding and Disruption and Induction of Premature Senescence by Disorazole C1. Journal of Pharmacology and Experimental Therapeutics. 328(3). 715–722. 32 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahiko Watanabe Breakdown of academic impact, for papers by Fei Qi Breakdown of academic impact, for papers by Emmanuel G. Fragoulis Breakdown of academic impact, for papers by Vilius Stribinskis Breakdown of academic impact, for papers by Tri M. Bui Nguyen Breakdown of academic impact, for papers by Juan Yang Breakdown of academic impact, for papers by Mukesh Kumar Sharma Breakdown of academic impact, for papers by Najma Farahani Breakdown of academic impact, for papers by Gagan B. Panigrahi Breakdown of academic impact, for papers by Megumi Ikeda
Rankless by CCL
2026